A new drug for the treatment of Parkinson's disease psychosis:pimavanserinSONG Pin-rao, WEN Li-min, JIANG Feng, LI Di, LIN Bin-bin, CAO Li-ping481-483
A theoretical framework of essential drug accessibility assessment in ChinaXI Xiao-yu, MA Dan-dan, CHEN Piao-piao, MAO Ning-ying489-493
Comparative analysis of new drug research and development strategy of representative enterprises in the field of diabetes mellitus based on patent perspectiveLIU Pei-ran, CONG Jun-jie, MENG Qing-hai494-498
Discussion of building a platform for the qualification of certification management about the drug clinical trialsOUYANG Zhao-lian, JING Shu-fang, FAN Yun-man, BAI Yang, CHI Hui, DU Yi-kun, FANG An499-503
Key considerations and issues of assessment for clinical value of drugsLIU Bing-lin, XUE Fei-ran504-508
Discussion on the prevention and cure of diabetes and its complication of AD from the angle of "treating encephalopathy"LAI Qiong, ZHANG Hai-yan, YANG Qi-yue, WAN Na, LIU Yang, YANG Ming509-513
Analysis on the adverse events and risk management in phase Ⅰ clinical trialsLI Yan-fen, HUANG Xing, WANG Rui-hua, MI Bo, HUANG Yu-hong514-518
The characteristics of the nano spray drying technology and its application in the pharmaceutics fieldsCHEN Juan, YANG Zhi-qiang, ZHANG Kun, PAN Feng, WANG Xing-lin519-524
Research progress for bile acids with its recptors in hepatocellular carcinomaZHU Shi-chao, ZHENG Xue-min, ZHOU Zhi-xing, XU Wei-ren525-529